SBMFF (Sino Biopharmaceutical) Other Operating Expense : $-19 Mil (TTM As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Sino Biopharmaceutical Other Operating Expense?

Sino Biopharmaceutical's Other Operating Expense for the six months ended in Dec. 2024 was $-29 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was $-19 Mil.

Sino Biopharmaceutical's quarterly Other Operating Expense increased from Dec. 2023 ($-27 Mil) to Jun. 2024 ($10 Mil) but then declined from Jun. 2024 ($10 Mil) to Dec. 2024 ($-29 Mil).

Sino Biopharmaceutical's annual Other Operating Expense declined from Dec. 2022 ($27 Mil) to Dec. 2023 ($-49 Mil) but then increased from Dec. 2023 ($-49 Mil) to Dec. 2024 ($-19 Mil).

Sino Biopharmaceutical Other Operating Expense Historical Data

The historical data trend for Sino Biopharmaceutical's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical Other Operating Expense Chart

Sino Biopharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

Get a 7-Day Free Trial

387.23

702.11

26.60

-48.53

-19.21

Sino Biopharmaceutical Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Operating Expense	Get a 7-Day Free Trial															324.03	-20.96	-27.50	10.26	-29.43

Sino Biopharmaceutical Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-19 Mil.

Sino Biopharmaceutical Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biopharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (OTCPK:SBMFF) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

SBHMY:USA 01177:Hong Kong SMZ1:Germany

Address

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG

Website

https://www.sinobiopharm.com

Listed on the Hong Kong Stock Exchange in 2000, Sino Biopharmaceutical is one of the largest Chinese drugmakers. It started with generic drug manufacturing. Since 2018, Sino Biopharm has been actively pivoting into an innovative drugmaker after the Chinese government launched its volume-based procurement policy for the healthcare industry. As of 2024, 41.8% of the firm's total revenue comes from its innovative product category, which includes innovative drugs and biosimilar drugs. Sino Biopharm's biggest revenue segment is oncology medicines, accounting for 37.2% of total revenue, followed by hepatitis, surgery/analgesia, respiratory, and cardio-cerebral vascular therapeutic areas.